Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, oncology equipment maker Varian Medical Systems
With that in mind, let's take a closer look at Varian's business and see what CAPS investors are saying about the stock right now.
|Founded (founded)||Palo Alto, Calif. (1948)|
|Market Cap||$6.8 billion|
|Industry||Health care equipment|
|Trailing-12-Month Revenue||$2.7 billion|
|Management||CEO Timothy Guertin
CFO Elisha Finney
|Return on Equity (average, past 3 years)||29%|
|Cash/Debt||$648.4 million / $161.8 million|
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 96% of the 400 members who have rated Varian believe the stock will outperform the S&P 500 going forward.
I think the recent pull-back provides a good entry-point for [Varian]. Their revenue and EPS are as solid as ever and rumor is that their managment may be expecting increased demand. Varian has been an outperformer for years and I see no reason this trend will stop anytime soon.
If you want market-beating returns, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future. Of course, despite its four-star rating, Varian may not be your top choice.
If that's the case, we've compiled a special free report for investors called "Discover the Next Rule-Breaking Multibagger," which uncovers another growth play with big potential. The report is 100% free, but it won't be around forever, so click here to access it now.
Want to see how well (or not so well) the stocks in this series are performing? Follow the new TrackPoisedTo CAPS account.